Class 546/227 - The -C(=X)- is part of a -C(=X)X- group, wherein the X's are the same or diverse chalcogens

Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the is part of a group, in which the
No. of patents: 111
Last issue date: 12/13/2011

«First «Previous1 2 3 Next»Last»

Number	Title	Issue Date
8076485	Methylphenidate derivatives and uses of them The present invention provides methods of using compounds of formula I: and salts and prodrugs thereof, wherein n, R1 and R2 are defined herein. The invention also provides certain novel compounds of f...	12/13/2011
7683175	Process of making optically pure L-pipecolic acid and process of making anesthetics and intermediates therefrom The present invention describes a novel process of preparation of optically pure L-Pipecolic acid and an improved process for the conversion of L-pipecolic acid to L-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide, its hydrochloride salt and hydrochloride mo...	03/23/2010
7439257	Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics The invention relates to a compound of formula (I): Wherein m, n, X, Y, R1, R2, R3 and R4 are as defined herein. The invention also relates to the use of same in therapeutics.	10/21/2008
7368443	2,6-disubstituted piperidines and piperazine compounds The present invention is directed to 2,6-disubstituted piperidine and piperazine analogs having the following general formula: which are used to treat diseases of the central nervous system, drug abuse, and withdrawal there...	05/06/2008
7351719	Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds The present invention relates to amide compounds of general formula I wherein the groups and residues A, B, b, W, X, Y, Z, R1, R2 and R3 have the meanings given in claim 1. Moreover t...	04/01/2008
7314844	Process for the cyanation aldehydes A process for cyanating an aldehyde is provided. The process comprises reacting the aldehyde with: i) a cyanide source which does not comprise a Si—CN bond or a C—(C═O)—CN moiety; and ii) a substrate susceptible to nucleophilic atta...	01/01/2008
7238709	Therapeutic carbamates This invention relates to hindered carbamate derivatives that are muscarinic receptor antagonists, pharmaceutical compositions comprising such compounds, and methods of preparing these compounds. ...	07/03/2007
7214714	20-hydroxyeicosatetraenoic acid production inhibitors A hydroxyformamidine compound represented by the following formula or a pharmaceutically acceptable salt thereof [wherein R1 represents a substituted morpholino group, a substituted piperidino group, a...	05/08/2007
7115631	Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate In one aspect, the present invention is directed to methods for treating fatigue, neurobehavioral slowing and other cognitive disorders and defects due to cancers and treatments associated with cancers, and similar conditions. In a further aspect, the present invent...	10/03/2006
7109215	Compounds possessing neuronal activity The present invention relates to compounds, methods and pharmaceutical compositions for stimulating the growth of neurites in nerve cells. The compounds and the compositions and methods that utilize them can be used, either alone or in conjunction with a neurotrophi...	09/19/2006
7034043	Cell adhesion inhibitors A cell adhesion inhibitor of the general formula: R3-L-L′-R1 is disclosed. An inhibitor of the present invention interacts with VLA-4 molecules and inhibits VLA-4 dependent cell adhesion. Also disclosed are methods for pre...	04/25/2006
6969768	Preparation of 4-haloalkylnicotinic esters A process for preparing 4-haloalkylnicotinic esters of the formula (I), where RF is (C1-C4)-haloalkyl and R is (C1-C6)-alkyl; w...	11/29/2005
6962998	Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative Disclosed are a method for producing racemic piperidine derivatives by processing optically-active piperidine derivatives in a hydrogen atmosphere in the presence of a reducing catalyst; and a method for producing optically-active piperidine derivatives or their aci...	11/08/2005
6949545	Heterocyclic side chain containing, n-substituted metalloprotease inhibitors Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to the following Formula (I):	09/27/2005
6943177	Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies Cis-2,6-disubstituted piperdine analogs, or lobeline analogs, having the general formula: are used to treat diseases of the central nervous system, drug abuse and withdrawal therefrom as well as to treating eating diso...	09/13/2005
6852738	Acyl sulfamides for treatment of obesity, diabetes and lipid disorders A class of acyl sulfamides comprises compounds that are potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compounds may be useful in the treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (...	02/08/2005
6693117	Compounds with analgesic effect Compounds of general formula (I) ##STR1## are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the ...	02/17/2004
6677454	Imaging agents for diagnosis of Parkinson's disease Generally, the present invention is directed to central nervous system dopamine transporter-imaging agents and methods of use thereof. In certain embodiments, the present invention relates to radiolabeled piperidine derivatives for use as imaging agents i...	01/13/2004
6664271	Immunopotentiator agents Novel compounds and methods for preparing same, immunopotentiating compositions, and a method for potentiating the immune system of a host animal. The method comprises administering to the animal an effective amount of an immunopotentiating compound of Fo...	12/16/2003
6579971	Method of producing 3,4-dehydroprolines and 3,4-dehydropiperidines A process for preparing compounds of the formula I ##STR1## in which R is hydrogen, C1 -C6 -alkoxy, --NHC1 -C6 -alkyl, --N(C1 -C6 -alkyl)2, OH, NH2 R1 is hydroge...	06/17/2003
6538137	Cyanobiphenyl derivatives Intermediates represented by the following formula: ##STR1## (wherein R1 is a hydrogen atom, an alkyl group, an aryl group, an aralkyl group or the like; X is a carboxyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an aralkoxycarbo...	03/25/2003
6455545	Compounds with analgesic effect Compounds of general formula (I) ##STR1## are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the ...	09/24/2002
6380220	Derivatives from piperidine-keto acid, their preparation and use Piperidineketocarboxylic acid derivatives of the general formula I ##STR1## and their tautomeric and isomeric forms, and physiologically tolerable salts thereof, where the variables have the meanings given in the description, preparation of these compound...	04/30/2002
6362373	Chiral amino alcohols and process for preparation of same The disclosed invention comprises a compound having the formula: ##STR1## in which R1 and R2 independently represent a hydrogen or an alkyl group of 4 carbon atoms or greater. Further disclosed is a process for the preparation of the...	03/26/2002
6358982	Heterocyclyl sulphonamide derivatives The present invention relates to the potentiation of glutamate receptor function using certain heterocyclyl sulphonamide derivatives. It also relates to novel heterocyclyl sulphonamide derivatives, to processes for their preparation and to pharmaceutical ...	03/19/2002
6339159	Optically active ଱-aminonitrile and process for producing ଱-amino acid An aldehyde compound is reacted with an amino compound and hydrogen cyanate in the presence of a chiral zirconium catalyst obtained by mixing a zirconium alkoxide with an optically active binaphthol compound....	01/15/2002
6319937	Isoxazoline fibrinogen receptor antagonists This invention relates to novel isoxazolines of formula (I): ##STR1## or a pharmaceutically acceptable salt form thereof. This invention also relates to novel isoxazolines of formula (I) which are useful as antagonists of the platelet glycoprotein IIb/III...	11/20/2001
6172234	Optically active cyclic amino acid ester derivatives and processes for producing the same There are disclosed a process for producing the optically active cyclic amino acid ester derivative of the formula (I): ##STR1## by optical resolution method, a process for producing the same and a process for producing an optically active cyclic amino ac...	01/09/2001
6172233	Process for making paroxetine Compounds of structure (2) are prepared by reaction of an arecoline analogue of structure(4) with an organometallic compound containing an X-substituted phenyl group, such as a compound of structure (3). ##STR1## Suitably the compound of structure (3) is ...	01/09/2001
6165236	Poly(oxyalkylene) pyridyl and piperidyl esters and fuel compositions containing the same A poly(oxyalkylene)pyridyl or piperidyl ester having the formula: ##STR1## or a fuel-soluble salt thereof; wherein A is a nitrogen-containing ring selected from the group consisting of 3-pyridyl, 4-pyridyl, 3-piperidyl and 4-piperidyl; R1 ...	12/26/2000
6159989	Antagonists of gonadotropin releasing hormone There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both m...	12/12/2000
6110944	LTA₄, hydrolase inhibitors The present invention provides compounds having the structure Ar1 --Q--Ar2 --O--(CH2)n --Z and pharmaceutically acceptable salts and stereoisomers thereof that are useful in the treatment of inflammatory diseases which ar...	08/29/2000
6051723	3-aryl-tetronic acid derivatives The present invention relates to new 3-aryl-4-hydroxy-Ɗ3 -dihydrofuranone derivatives of the formula (I) ##STR1## in which A and B together with the carbon atom to which they are bonded form an unsubstituted or substituted 5- to 7-membere...	04/18/2000
6020347	4-substituted-4-piperidine carboxamide derivatives 4-Substituted-4-piperidinecarboxamides of Formula I are antagonists of VLA-4 and/or 댔 댧, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds ma...	02/01/2000
5942014	Pyridyl and piperidyl esters of polyalklphenoxyalkanols and fuel compositions containing the same Pyridyl and piperidyl esters of polyalkylphenoxyalkanols having the formula: ##STR1## or a fuel soluble salt thereof, wherein A is selected from the group consisting of 3-pyridyl, 4-pyridyl, 3-piperidyl, and 4-piperidyl; R1 is a polyalkyl ...	08/24/1999
5932595	Matrix metalloprotease inhibitors The present invention relates to compounds of Formula I: ##STR1## that are matrix metalloprotease inhibitors, pharmaceutical compositions containing them, methods for their use and methods of preparing these compounds....	08/03/1999
5929243	Process for the preparation of (S)-3-carbethoxy-3-benzylpiperidine The present invention is concerned with a novel process for the preparation of a compound of the formula: ##STR1## This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity....	07/27/1999
5834490	Cyclopropyl derivatives, preparation method there-of and applications Cyclopropyl derivatives of formula (I) wherein R is cyclopropyl or methyllopropyl are prepared by reaction of 2,6-dibromohexanoyl chloride with 2,6-dimethylaniline in the presence of a base at 0°-25° C. to give 2,6-dibromohexanoyl-2,6-dimethylanilide w...	11/10/1998
5824722	Stabilizer and resin composition containing the same The present invention provides a stabilizer comprising a substituted cyclohexene compound of a hindered piperidine type wherein the 1- and 2-positions on a cyclohexene ring are doubly bonded, a carbon atom situated at the 4-position and/or the 5-position ...	10/20/1998
5760035	Therapeutic agents Compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof in which R1, R2 and R3 independently represent hydrogen, hydroxy, halo, alkyl or alkoxy; ALK1 represents a C2-6 alkyl...	06/02/1998

«First «Previous1 2 3 Next»Last»

PatentStorm

Quotables

PatentStorm News

Class 546/227 - The -C(=X)- is part of a -C(=X)X- group, wherein the X's are the same or diverse chalcogens